Patience David

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$17,543.74

Insider Activity of Patience David

According to the SEC Form 4 filings, Patience David, being in a position of

  1. Chief Financial Officer at Accelerate Diagnostics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 13646 shares for $11,904,
    over all time since 2023-04-13, has bought 0 shares, and sold 17778 shares for $17,544.

The largest sale of all time was on 2024-04-09 and amounted to 13296 shares of Accelerate Diagnostics, Inc. for $11,568.

Biography of Patience David

No biography is available at this moment.

2024-04-09SaleAccelerate Diagnostics, Inc.
AXDX
Chief Financial Officer
13,296
0.0621%
$0.87$11,568+61.85%
2024-02-26SaleAccelerate Diagnostics, Inc.
AXDX
Chief Financial Officer
350
0.0016%
$0.96$336+32.81%
2023-12-13SaleAccelerate Diagnostics, Inc.
AXDX
Chief Financial Officer
97
0.0006%
$4.39$426-71.86%
2023-10-13SaleAccelerate Diagnostics, Inc.
AXDX
Chief Financial Officer
96
0.0007%
$5.83$560-77.38%
2023-09-13SaleAccelerate Diagnostics, Inc.
AXDX
Chief Financial Officer
96
0.0007%
$6.53$627-78.74%
2023-08-14SaleAccelerate Diagnostics, Inc.
AXDX
Chief Financial Officer
95
0.0006%
$6.80$646-81.08%
2023-07-13SaleAccelerate Diagnostics, Inc.
AXDX
Chief Financial Officer
92
<0.0001%
$6.90$635-45.25%
2023-06-13SaleAccelerate Diagnostics, Inc.
AXDX
Chief Financial Officer
1,287
0.0015%
$0.90$1,158-45.21%
2023-05-15SaleAccelerate Diagnostics, Inc.
AXDX
Chief Financial Officer
1,222
0.0011%
$0.69$843-34.47%
2023-04-13SaleAccelerate Diagnostics, Inc.
AXDX
Chief Financial Officer
1,147
0.0011%
$0.65$746-13.19%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.